Kythera Biopharmaceuticals Inc Watch

from S-3 46 pages Kythera Biopharmaceuticals, Inc. Indenture Dated as of , 20 Wilmington Trust, National Association Trustee

from 8-K 19 pages Registration Rights Agreement

from 8-K 17 pages For Value Received, Kythera Biopharmaceuticals, Inc., a Delaware Corporation (“Borrower”), Located at 27200 West Agoura Road, Suite 200, Calabasas, Ca 91301, Promises to Pay to the Order of Kythera Holdings Ltd., a Wholly-Owned Subsidiary of Borrower and a Company Incorporated Under the Laws of Bermuda (“Lender”), the Principal Amount of Fifty One Million and No/100 Dollars ($51,000,000.00) (As Such Amount May Be Increased or Decreased From Time to Time Pursuant to the Terms Hereof, the “Principal Amount”), Together With Interest on the Principal Amount for the Period Commencing on the Date Hereof Until All Amounts Due Hereunder Are Paid in Full in Cash, at the Rates Per Annum and on the Dates Provided Below. 1. Definitions. as Used in This Note, the Following Terms Have the Following Meanings

from S-1/A ~5 pages Amendment No. 01 Dated July 23, 2012 to That Certain Preferred Stock Warrant Agreement Dated as of December 30, 2011, (The “Warrant”) by and Between Lighthouse Capital Partners VI, L.P. (“Holder”) and Kythera Biopharmaceuticals, Inc. (“Company”)

from S-1/A 2 pages Delaware June 2004 Seal Kythera Biopharmaceuticals, Inc. Corporate This Certifies That Is the Record Holder of Dated: Kb Incorporated Under the Laws of the State of Delaware Fully Paid and Nonassessable Shares of Common Stock, $.00001 Par Value, of Kythera Biopharmaceuticals, Inc. Transferable on the Books of the Corporation in Person or by Duly Authorized Attorney Upon Surrender of This Certificate Properly Endorsed. This Certificate Is Not Valid Until Countersigned by the Transfer Agent and Registered by the Registrar. Witness the Facsimile Seal of the Corporation and the Facsimile Signatures of Its Duly Authorized Officers. Cusip 501570 10 5 See Reverse for Certain Definitions Secretary & General Counsel President & Chief Executive Officer Countersigned and Registered: Wells Fargo Bank, N.A. Transfer Agent and Registrar By: Authorized Signature

from S-1 10 pages Kythera Biopharmaceuticals, Inc. Effective as of December 30, 2011 Void After December 30, 2021

from S-1 13 pages Kythera Biopharmaceuticals, Inc. Effective as of March 21, 2011 Void After March 21, 2021

from S-1 9 pages Aestherx, Inc. Warrant to Purchase Shares